{ "as_of": "2026-11-06", "cmr": "ca-cm-kg/CSE/RHEL", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Rhelion Life Sciences Corp. (CSE: RHEL) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nRhelion Life Sciences Corp. is listed on the CSE under the ticker RHEL. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the sector is Life Sciences, and the segment is not on the record. The jurisdiction is not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 21 filings in the twelve months to 2026-11-06, across 16 filing days. The filings comprise 20 newswire releases and 1 corporate action. The median gap between filing days is 4 days. The latest filing is a newswire release dated 2026-11-03, 3 days before the record date. The CSE median cadence gap is 19.5 days, with a median of 6.0 filings and a median latency of 17.0 days. The Life Sciences sector median cadence gap is 17.5 days, with a median of 7.0 filings and a median latency of 14 days.\n\n## Auditor\n\nThe auditor of record is Clearhouse LLP, with its location not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no delisting, domicile change, listing, name change or segment move events. The halt flag reads listed, not halted.\n\n## Orderability\n\nUnder rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, the outcome for paragraph (o) of the definition is signal ACM-200 and is determinable. The outcome for paragraph (q) of the definition is signal ACM-200 and is determinable. The chapter is as of 2026-11-04.\n\n## Coverage\n\nThe field has not been read, so the number of research houses named on the issuer's investor-relations page is not on the record.\n\n## Open research\n\nThe field has not been read, so the count of openly published research notes is not on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. The record holds no sealed years for this issuer, and the market's earliest sealed date is not on the record. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n6 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)\n- https://mcp.ca-cm-kg.ai/events/CSE/RHEL (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://thecse.com/listings/rhelion-life-sciences-corp/ (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/CSE/RHEL (the record)\n", "market": "CA", "node": "ca-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-10", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "CSE", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/listings/rhelion-life-sciences-corp/", "state": "sourced", "value": "Clearhouse LLP" }, "auditor_firm_id": { "market": "CA", "state": "not_on_record" }, "auditor_location": { "market": "CA", "state": "not_on_record" }, "changes": [] }, "cmr": "ca-cm-kg/CSE/RHEL", "coverage": { "note": "the coverage field has not been read for this issuer", "state": "not_read" }, "disclosure": { "against": { "exchange": { "issuers": 724, "median_cadence_gap_days": 19.5, "median_filings": 6, "median_latency_days": 17, "name": "CSE" }, "sector": { "issuers": 200, "median_cadence_gap_days": 17.5, "median_filings": 7, "median_latency_days": 14, "name": "Life Sciences" } }, "by_type": { "corporate_action": 1, "newswire_release": 20 }, "cadence_median_gap_days": 4, "filing_days": 16, "filings": 21, "latency_days": 3, "latest": [ { "category": null, "date": "2026-11-03", "source": "https://www.newsfilecorp.com/release/322278/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Ships-PEX010-to-the-University-of-Southern-California-for-the-Expanded-Mindfulness-Assisted-Psychedelic-Therapy-Trial", "title": "Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial", "type": "newswire_release" }, { "category": null, "date": "2026-11-03", "source": "https://www.newsfilecorp.com/release/322020/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Completes-New-Extraction-of-IBEX011-Its-Naturally-Derived-Ibogaine-Drug-Candidate-and-Commences-Stability-Testing", "title": "Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes New Extraction of IBEX011, Its Naturally Derived Ibogaine Drug Candidate, and Commences Stability Testing", "type": "newswire_release" }, { "category": null, "date": "2026-11-02", "source": "https://www.newsfilecorp.com/release/322020/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Completes-New-Extraction-of-IBEX011-Its-Naturally-Derived-Ibogaine-Drug-Candidate-and-Commences-Stability-Testing?lang=fr", "title": "Rhelion Life Sciences' Wholly Owned Subsidiary Filament ...", "type": "newswire_release" }, { "category": null, "date": "2026-11-02", "source": "https://www.newsfilecorp.com/release/322020/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Completes-New-Extraction-of-IBEX011-Its-Naturally-Derived-Ibogaine-Drug-Candidate-and-Commences-Stability-Testing", "title": "Rhelion Life Sciences' Wholly Owned Subsidiary Filament ...", "type": "newswire_release" }, { "category": null, "date": "2026-10-29", "source": "https://www.newsfilecorp.com/release/321406/Rhelion-Life-Sciences-Wholly-Owned-Subsidiary-Filament-Health-Signs-Agreement-to-Supply-PEX010-to-Linkoping-University-for-PsiloSAD-Trial-in-Social-Anxiety-Disorder", "title": "Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Agreement to Supply PEX010 to Linkoping University for PsiloSAD Trial in Social Anxiety Disorder", "type": "newswire_release" } ], "latest_filing_date": "2026-11-03", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.ca-cm-kg.ai/events/CSE/RHEL", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "CSE" }, "isin": { "market": "CA", "reason": "no ISIN found on issuer pages", "state": "not_on_record" }, "jurisdiction": { "market": "CA", "reason": "not searched", "state": "not_on_record" }, "lei": { "market": "CA", "reason": "no ISIN", "state": "not_on_record" }, "name": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Rhelion Life Sciences Corp." }, "sector": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Life Sciences" }, "security_type": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Corporate" }, "segment": { "market": "CA", "state": "not_on_record" }, "ticker": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "RHEL" }, "website": { "market": "CA", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": [], "domicile_change": [], "listing": [], "name_change": [], "segment_move": [] }, "market": "CA", "node": "ca-cm-kg", "numbers_hash": "sha256:323193e81086d2bf93779ed8a3f149d81a443abc4a887d14e2ac83829aff71dc", "open_research": { "rows": [], "state": "not_read" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "Paragraph (o) of the definition", "Paragraph (q) of the definition" ], "outcomes": { "Paragraph (o) of the definition": { "determinable": true, "signal": "ACM-200" }, "Paragraph (q) of the definition": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json", "door": "https://mcp.ca-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1", "section": "ca.aio.v11" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.ca-cm-kg.ai/record/CSE/RHEL", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-08", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100", "value": "listed, not halted" } }, "numbers_hash": "sha256:323193e81086d2bf93779ed8a3f149d81a443abc4a887d14e2ac83829aff71dc", "path": "/ca/CSE/RHEL", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "Rhelion Life Sciences Corp. is listed on the CSE under the ticker RHEL. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the sector is Life Sciences, and the segment is not on the record. The jurisdiction is not on the record. The listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 21 filings in the twelve months to 2026-11-06, across 16 filing days. The filings comprise 20 newswire releases and 1 corporate action. The median gap between filing days is 4 days. The latest filing is a newswire release dated 2026-11-03, 3 days before the record date. The CSE median cadence gap is 19.5 days, with a median of 6.0 filings and a median latency of 17.0 days. The Life Sciences sector median cadence gap is 17.5 days, with a median of 7.0 filings and a median latency of 14 days.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is Clearhouse LLP, with its location not on the record. The record holds no auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record holds no delisting, domicile change, listing, name change or segment move events. The halt flag reads listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "Under rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, the outcome for paragraph (o) of the definition is signal ACM-200 and is determinable. The outcome for paragraph (q) of the definition is signal ACM-200 and is determinable. The chapter is as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "The field has not been read, so the number of research houses named on the issuer's investor-relations page is not on the record.", "title": "Coverage" }, { "id": "open_research", "text": "The field has not been read, so the count of openly published research notes is not on the record.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The market's vintage is not sealed. The record holds no sealed years for this issuer, and the market's earliest sealed date is not on the record. The live record began 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "6 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://thecse.com/api/webapi/listed-companies/" }, { "for": "the disclosure lines", "source": "https://mcp.ca-cm-kg.ai/events/CSE/RHEL" }, { "for": "the halt flag", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100" }, { "for": "the auditor", "source": "https://thecse.com/listings/rhelion-life-sciences-corp/" }, { "for": "the orderability chapter", "source": "https://mcp.ca-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.ca-cm-kg.ai/record/CSE/RHEL" } ], "title": "Rhelion Life Sciences Corp. (RHEL) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }